Page last updated: 2024-08-22

platinum and cytarabine

platinum has been researched along with cytarabine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19906 (75.00)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atkins, LM; Glae, GR; Meischen, SJ; Smith, AB; Walker, EM1
Foon, KA; Gale, RP; Naiem, F; Yale, C1
Burchenal, JH; Carter, SK1
Gang, M; Kline, I; Sirica, AE; Venditti, JM; Woodman, RJ1
Bräuerová, J; Drobník, J; Kutinová, L; Vonka, V1
Drobník, J; Kutinová, L; Vonka, V; Závadová, H1
Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W1
Hargis, S; Jiang, Y; Liu, X; Nowak, B; Plunkett, W1

Reviews

1 review(s) available for platinum and cytarabine

ArticleYear
New cancer chemotherapeutic agents.
    Cancer, 1972, Volume: 30, Issue:6

    Topics: Aldehydes; Amides; Amines; Animals; Antineoplastic Agents; Asparaginase; Azacitidine; Azaguanine; Bleomycin; Carmustine; Chlorides; Cyclization; Cyclohexanes; Cytarabine; Cytidine; Doxorubicin; Glycosides; Humans; Hydroxyurea; Imidazoles; Leukemia, Lymphoid; Leukemia, Myeloid; Mice; Nitrosourea Compounds; Picolinic Acids; Platinum; Podophyllotoxin; Streptozocin; Thiosemicarbazones; Triazenes

1972

Trials

1 trial(s) available for platinum and cytarabine

ArticleYear
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Mitoxantrone; Platinum; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Failure

1995

Other Studies

6 other study(ies) available for platinum and cytarabine

ArticleYear
Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
    Journal of the National Cancer Institute, 1976, Volume: 57, Issue:6

    Topics: Animals; Cell Survival; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluorouracil; Leukemia L1210; Mesylates; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organometallic Compounds; Platinum; Propylamines; Vincristine

1976
Acute myelogenous leukemia: morphologic classification and response to therapy.
    Leukemia research, 1979, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Middle Aged; Platinum; Thioguanine

1979
The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
    Chemotherapy, 1973, Volume: 18, Issue:3

    Topics: Amines; Animals; Antineoplastic Agents; Azacitidine; Camptothecin; Carmustine; Chlorides; Cyclophosphamide; Cytarabine; Drug Synergism; Emetine; Fluorouracil; Ketones; Leukemia L1210; Male; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Piperazines; Platinum; Propane; Time Factors

1973
Increase of Epstein-Barr-virus-positive cells in EB3 cultures after treatment with cis-dichloro-diammine-platinum.
    Journal of the National Cancer Institute, 1972, Volume: 48, Issue:5

    Topics: Amines; Bromodeoxyuridine; Cell Line; Cells, Cultured; Chlorides; Cytarabine; DNA, Viral; Fluorescent Antibody Technique; Herpesviridae; Herpesvirus 4, Human; Humans; Platinum; Stimulation, Chemical

1972
Influence of cis-dichlorodiammineplatinum (II) on growth of SV 40 virus in green monkey kidney cells.
    Archiv fur die gesamte Virusforschung, 1972, Volume: 39, Issue:1

    Topics: Animals; Antigens, Neoplasm; Antigens, Viral; Cell Line; Complement Fixation Tests; Cytarabine; Fluorescent Antibody Technique; Haplorhini; Kidney; Organometallic Compounds; Platinum; Simian virus 40; Time Factors; Viral Proteins; Virus Replication

1972
Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:10

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cricetinae; Cytarabine; Dacarbazine; DNA Breaks; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Homologous Recombination; Humans; Platinum; Poly (ADP-Ribose) Polymerase-1; Temozolomide; Tumor Suppressor Protein p53

2016